News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CAS Medical Systems, Inc. (CASM) Announces Initial Sales of the Next-Generation FORE-SIGHT ELITE Cerebral Oximeter


9/13/2013 8:59:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRANFORD, Conn., Sept. 12, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it recently recorded the first commercial sale of its next generation FORE-SIGHT ELITEā„¢ Cerebral Oximetry products. The Company received U.S. Food and Drug Administration (FDA) clearance for the ELITE in mid-April and began a controlled product introduction in August with select customers for evaluation purposes.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES